Acquisition of Southern Cross Diagnostics accelerates growth, profitability, and product expansion, with immediate accretive impact and direct access to key customers in Australia and New Zealand. Capital raise was oversubscribed, strengthening the balance sheet and supporting future product launches and partnerships.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.